Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1987 Mar;71(3):220–223. doi: 10.1136/bjo.71.3.220

Bietti's tapetoretinal degeneration with marginal corneal dystrophy (crystalline retinopathy): case report.

R J Harrison, R R Acheson, J C Dean-Hart
PMCID: PMC1041124  PMID: 3493804

Abstract

A patient with Bietti's tapetoretinal degeneration and marginal corneal dystrophy is reported on. Refractile deposits found in both the retina and cornea are the most striking feature of this condition. Apart from a slight reduction in left visual acuity there were no visual symptoms. The dark adapted electroretinogram was abnormal. No metabolic disturbance was detected.

Full text

PDF
220

Images in this article

221Image
on p.221
221Image
on p.221
222Image
on p.222
222Image
on p.222
222Image
on p.222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMSTERDAM D., SCHNEIERSON S. S. Enhancement of staphylococcal virulence for mice by intraperitoneal cortisone acetate, cholesterol and lecithin. Nature. 1960 Apr 2;186:101–102. doi: 10.1038/186101a0. [DOI] [PubMed] [Google Scholar]
  2. Bagolini B., Ioli-Spada G. Bietti's tapetoretinal degeneration with marginal corneal dystrophy. Am J Ophthalmol. 1968 Jan;65(1):53–60. doi: 10.1016/0002-9394(68)91028-3. [DOI] [PubMed] [Google Scholar]
  3. Bullock J. D., Albert D. M. Flecked retina. Appearance secondary to oxalate crystals from methoxyflurane anesthesia. Arch Ophthalmol. 1975 Jan;93(1):26–31. doi: 10.1001/archopht.1975.01010020030004. [DOI] [PubMed] [Google Scholar]
  4. Fielder A. R., Garner A., Chambers T. L. Ophthalmic manifestations of primary oxalosis. Br J Ophthalmol. 1980 Oct;64(10):782–788. doi: 10.1136/bjo.64.10.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Francois J., De Laey J. J. Bietti's crystalline fundus dystrophy. Ann Ophthalmol. 1978 Jun;10(6):709–716. [PubMed] [Google Scholar]
  6. Fraunfelder F. T. Interim report: National Registry of possible Drug-induced Ocular Side Effects. Ophthalmology. 1980 Feb;87(2):87–90. doi: 10.1016/s0161-6420(80)35263-9. [DOI] [PubMed] [Google Scholar]
  7. Gilbert W. R., Jr, Smith J. L., Nyhan W. L. The Sjogren-Larsson syndrome. Arch Ophthalmol. 1968 Sep;80(3):308–316. doi: 10.1001/archopht.1968.00980050310003. [DOI] [PubMed] [Google Scholar]
  8. Grizzard W. S., Deutman A. F., Nijhuis F., de Kerk A. A. Crystalline retinopathy. Am J Ophthalmol. 1978 Jul;86(1):81–88. doi: 10.1016/0002-9394(78)90019-3. [DOI] [PubMed] [Google Scholar]
  9. Mauldin W. M., O'Connor P. S. Crystalline retinopathy (Bietti's tapetoretinal degeneration without marginal corneal dystrophy). Am J Ophthalmol. 1981 Nov;92(5):640–646. doi: 10.1016/s0002-9394(14)74655-0. [DOI] [PubMed] [Google Scholar]
  10. Sanderson P. O., Kuwabara T., Stark W. J., Wong V. G., Collins E. M. Cystinosis. A clinical, histopathologic, and ultrastructural study. Arch Ophthalmol. 1974 Apr;91(4):270–274. doi: 10.1001/archopht.1974.03900060280006. [DOI] [PubMed] [Google Scholar]
  11. Takki K. Gyrate atrophy of the choroid and retina associated with hyperornithinaemia. Br J Ophthalmol. 1974 Jan;58(1):3–23. doi: 10.1136/bjo.58.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Welch R. B. Bietti's tapetoretinal degeneration with marginal corneal dystrophy crystalline retinopathy. Trans Am Ophthalmol Soc. 1977;75:164–179. [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES